News

Deal Announcements

Aura Biosciences Bags Venture Capital Debt

Friday, January 10, 2014 5:34:00 AM PDT | VentureDeal
   Cambridge, Massachusetts  --  Biotechnology company Aura Biosciences has secured $1.34 million in venture capital debt investment, according to an SEC regulatory filing.

Aura aims to in-license promising biotechnologies and commercialize them more efficiently than other companies.

Investors in the financing were not disclosed, nor was how the company intends to use the funding proceeds.

Email Page  Email Page | Print Page Print Page

Free Trial

Want unlimited access to the complete database with thousands of technology companies, VCs and transactions for only $25 per month?

Start your Free 14 Day Trial now – no obligation or credit card required.

Free 14 day trial. No Obligation. Click to Register.
Venturedeal Twitter Venturedeal Facebook Venturedeal Linkedin


PCI - Level1